4th Annual Genome Editing US Congress
April 7, 2020 - April 8, 2020
With gene editing tools becoming advanced enough to realize therapeutic potential, decision-makers working in academia and pharma are looking to consolidate their techniques to facilitate disease modelling, drug development and clinical studies.
The NextGen Genomics Series US includes:
- Over 350 end users representing research & academic institutions, clinical research institutions, healthcare organizations, pharmaceutical and biotech companies.
- Three programs bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.
- Over 80 case studies, solution & technology presentations and 2 interactive workshops.
When: April 7-8, 2020